Table 2.
Compound | IC50 (μm) | Kb (μm) |
---|---|---|
FM2-10 | 1.6 ± 0.1 | 15.8 ± 10 |
FM1-43 | 0.4 ± 0.1 | 0.33 ± 0.15 |
Atropine | 0.0006 ± 0.0003 | 0.0017 ± 0.0009 |
Pirenzepine | 1.6 ± 0.6 | 0.13 ± 0.02 |
Methoctramine | 12.9 ± 4.6 | >3 μm |
4-DAMP | 0.0021 ± 0.0002 | 0.00077 ± 0.00009 |
Data represent the means ±s.e.m. of n = 3–4 experiments. The IC50 is defined as the concentration of antagonist that inhibits the maximum EFS-evoked contractions by 50%. The Kb is the concentration of antagonist producing a 2-fold leftward shift in the acetylcholine concentration–response curve. The absolute potency and rank order of potency for the reference compounds is comparable to that reported previously in studies of muscarinic receptor agonist-induced contractions of guinea-pig trachealis (Eglen et al. 1999).